Search

everythinglearnresearchcommunity

for

Search:↓

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Topical finasteride cream reduces hair growth perception in women with idiopathic hirsutism.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Topical finasteride may help treat facial hirsutism in women.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

JAK inhibitors show promise as a future treatment for hair loss.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Experts met to improve care for ichthyosis patients in Spain.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Dutasteride helps increase hair density in patients with female-pattern hair loss by activating a new growth mechanism.

Minoxidil improved rat skin flap survival but was less effective than surgical methods.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

Small injections of dutasteride improved hair thickness in men with hair loss without major side effects.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Minoxidil helps prevent stress-caused hair loss in mice.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.